Evidence map›Paper›PMID 23792571›Full record

ArticleCancer biology & therapy2013

Amyloid precursor-like protein 2 suppresses irradiation-induced apoptosis in Ewing sarcoma cells and is elevated in immune-evasive Ewing sarcoma cells.

Haley L Peters, Ying Yan, Tara M Nordgren, Christine E Cutucache, Shantaram S Joshi, Joyce C Solheim

Open access · bronzeAbstract read
In one paragraph

Article in Cancer biology & therapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma.Molecular therapy : the journal of the American Society of Gene Therapy · 2015
    Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Haley L PetersEppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE USA.
Ying Yan
Tara M Nordgren
Christine E Cutucache
Shantaram S Joshi
Joyce C Solheim
University of Nebraska at Omaha · USPediatrics and Genetics · USUniversity of Nebraska Medical Center · US

Funding

SUPPRESSIVE ROLE OF TGFBETA IN METASTASIS OF COLON CANCERP20RR018759 · NCRR · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI WAHL, JAMES K · 2003 to 2011
$17.9M
Tissue CoreP50CA127297 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI HOLLINGSWORTH, MICHAEL A. · 2008 to 2018
$17.1M
CHEMICAL CARCINOGENESIS &CANCER BIOLOGYT32CA009476 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Jennifer D. Black · 1988 to 2026
$6.2M
Nebraska Center for Cellular SignalingP20GM103489 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI JOHNSON, KEITH R · 2012 to 2012
$2.0M
Ewing's Sarcoma Resistance to Immunity and RadiationR03CA176557 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI SOLHEIM, JOYCE C · 2013 to 2014
$148k
NCI NIH HHS P50 CA127297NCI NIH HHS P50CA127297NCI NIH HHS R03 CA176557NCI NIH HHS R03CA176557NCI NIH HHS T32 CA009476NCI NIH HHS T32CA009476NCRR NIH HHS P20 RR018759NCRR NIH HHS P20RR018759NIGMS NIH HHS P20 GM103489NIGMS NIH HHS P20GM103489
6 · The paper itself

Abstract

Despite surgery, chemotherapy, and radiotherapy treatments, the children, adolescents, and young adults who are diagnosed with metastasized Ewing sarcoma face a dismal prognosis. Amyloid precursor-like protein 2 (APLP2) has recently been implicated in the survival of cancer cells and in our current study, APLP2's contribution to the survival of Ewing sarcoma cells was examined. APLP2 was readily detected in all Ewing sarcoma cell lines analyzed by western blotting, with the TC71 Ewing sarcoma cells expressing the lowest level of APLP2 among the lines. While irradiation induces apoptosis in TC71 Ewing sarcoma cells (as we determined by quantifying the proportion of cells in the sub-G 1 population), transfection of additional APLP2 into TC71 decreased irradiation-induced apoptosis. Consistent with these findings, in parallel studies, we noted that isolates of the TC71 cell line that survived co-culture with lymphokine-activated killer (LAK) cells (which kill by inducing apoptosis in target cells) displayed increased expression of APLP2, in addition to smaller sub-G 1 cell populations after irradiation. Together, these findings suggest that APLP2 lowers the sensitivity of Ewing sarcoma cells to radiotherapy-induced apoptosis and that APLP2 expression is increased in Ewing sarcoma cells able to survive exposure to cytotoxic immune cells.

Indexed as

Amyloid beta-Protein PrecursorApoptosisCell Line, TumorHumansNerve Tissue ProteinsSarcoma, EwingSignal TransductionTransfectionAmyloid beta-Protein PrecursorAPLP2 protein, humanNerve Tissue Proteinsamyloid precursor-like protein 2cytotoxicEwing sarcomaimmune evasionimmunotherapylymphokine-activated killer cellradiation

Identifiers

PMID23792571
PMCPMC3841215
OpenAlexW2134374536

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.